Blog

19 Articles

latex gloved hand holding monoclonal antibodies vial
Research
May 2, 2022 • 2 Min

A New Immunotherapy Combination for Metastatic Pancreatic Cancer

Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.

Wungki Park, M.D.
Research
December 15, 2021 • 3 Min

Claudin May Be the Next Big Target in Pancreatic Cancer Treatment

Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.

Dr. Tanios Bekaii-Saab
Research
June 3, 2021 • 4 Min

Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor

Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.

Fractal flame ribbons in whte and red on a black background
Research
May 15, 2020 • 2 Min

Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer

Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.

The tops of closed lab vials as seen from overhead against a blue-ish background
Research
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.

computer rendering of DNA in Brown and blue against a black background
Research
March 2, 2020 • 2 Min

Testing the Safety of an Immunotherapy Combination After Surgery

A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.

electron microscope image of concentric circles formed by reactive ion etching
Research
March 29, 2019 • 2 Min

Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer

Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.

A latex-gloved hand doing close lab work
Research
March 5, 2019 • 2 Min

Targeting Cancer-Associated Wasting With Experimental Immunotherapy

Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.

A human epithelial cell (DNA in blue) with increased numbers of centrosomes (green) amid a sea of normal cells.
Research
January 14, 2019 • 2 Min

Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer

Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.

Deirdre Cohen
Research
December 17, 2018 • 4 Min

Aiming to Improve Immunotherapy for Pancreatic Cancer

Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.

Clear flasks on a yellow background, filled with water colored blue, green, or red
Research
November 6, 2018 • 2 Min

Immunotherapy Combination Plus Radiation for Pancreatic Cancer

Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.

Particle based vaccines
Research
May 1, 2018 • 3 Min

Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1

Dr. Mark O’Hara outlines a collaborative clinical trial of two immunotherapy agents–a checkpoint inhibitor and a monoclonal antibody–plus standard chemotherapy.

DNA double helix
Research
October 25, 2017 • 4 Min

More Research Needed for Pancreatic Cancer Immunotherapy

Dr. Luis Diaz provides a status check for immunotherapy treatments for pancreatic cancer, including an explanation of different types.

Abstract image of roundish shapes packed together, in shades of yellow to black colorsv
Research
September 26, 2017 • 2 Min

Chemotherapy, Immunotherapy, and Radiation for Locally Advanced Pancreatic Cancer

A clinical trial combines chemotherapy, immunotherapy, including a pancreas vaccine, and SBRT to stop locally advanced pancreatic cancer.

Microscope image of a cross section of circular pancreas cells with lighter centers, stained pink
Research
March 23, 2017 • 2 Min

Two Types of Immunotherapy for Surgically Removable Pancreatic Cancer

A clinical trial compares the effectiveness of two different types of immunotherapy with standard treatment after pancreatic cancer surgery.

  • 1
  • 2